Reads to me like parallel research in the benefits of pbt434 while going into p1 so they have range of performance targets in p2 p3 trial design .
Ann: Prana commences research collaboration with Takeda, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $41.54K | 4.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 11136808 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4729475 | 10 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |